One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Innovative trials in heart failure, dyslipidaemias, and sinus node dysfunction
Filippo Crea
doi : 10.1093/eurheartj/ehad706
European Heart Journal, Volume 44, Issue 40, 21 October 2023, Pages 4203–4207
Somatic mutations in vascular wall function and age-associated disease
Gwladys Revêchon , Lara Garcia Merino , Piotr Machtel, and Maria Eriksson
Brain endothelium: a nexus for cerebral small vessel disease
Martin Dichgans 1,2,3,4*, Frank M. Faraci 5,6, and for the BRENDA Network
Silencing liver angiotensinogen synthesis as a novel approach to hypertension management: promises and challenges
Giovanna Liuzzo 1,2* and Massimo Volpe
Rapid, accurate publication and dissemination of clinical trial results: benefits and challenges
Faiez Zannad 1 *, Filippo Crea 2 , John Keaney 3 , Stuart Spencer 4 , Joseph A. Hill 5 , Marc A. Pfeffer 6 , Stuart Pocock 7 , Emma Raderschadt 8 , Joseph S. Ross9 , Chana A. Sacks10 , Harriette G. C. Van Spall 11 , Ron Winslow12 , and Mariell Jessup
Critical Reading of cardiovascular trials with neutral or negative results
Claudio Rapezzi 1,2†, Alberto Aimo 3,4 *, Iacopo Fabiani 4 , Vincenzo Castiglione 3,4 , Roberto Ferrari1 , Aldo Pietro Maggioni5 , and Luigi Tavazzi 2
Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial
Lama Ghazi1, Yu Yamamoto2, Michael Fuery2,3, Kyle O’Connor2, Sounok Sen3, Marc Samsky2,3, Ralph J. Riello2, Ravi Dhar4, Joanna Huang5, Temitope Olufade5, James McDermott5, Silvio E. Inzucchi6, Eric J. Velazquez3, Francis Perry Wilson2, Nihar R. Desai2,3, and Tariq Ahmad
Hospitalization for heart failure requires a PROMPT response
Nicholas K. Brownell1 and Gregg C. Fonarow
Atrial pacing minimization in sinus node dysfunction and risk of incident atrial fibrillation: a randomized trial
Mads Brix Kronborg 1,2*, Maria Hee Jung Park Frausing1,2, Jerzy Malczynski3, Sam Riahi 4,5, Jens Haarbo6, Katja Fiedler Holm4,5, Charlotte Ellen Larroudé6, Andi Eie Albertsen7, Lene Svendstrup8, Ulrik Hintze9, Ole Dyg Pedersen10, Ulla Davidsen11, Thomas Fischer12, Jens Brock Johansen 13, Jens Kristensen 1, Christian Gerdes1, and Jens Cosedis Nielsen 1,2, for the DANPACE II Investigators
Atrial pacing and atrial fibrillation in sinus node dysfunction: a relationship that remains elusive
Ratika Parkash
Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial
Béla Merkely 1*, Robert Hatala2, Jerzy K. Wranicz3, G?bor Duray 4, Csaba F?ldesi5, Zolt?n Som5, Marianna Németh1,6, Kinga Goscinska-Bis7, L?szl? Gellér1, Endre Zima 1, Istv?n Osztheimer 1, Levente Moln?r1, J?lia Kar?dy1,8, Gerhard Hindricks9, Ilan Goldenberg 10, Helmut Klein10, M?ty?s Szigeti1,11,12, Scott D. Solomon 13, Valentina Kutyifa 1,10†, Attila Kov?cs 1†, and Annam?ria Kosztin 1†; on behalf of the BUDAPEST CRT Upgrade Investigators
The BUDAPEST trial: a good grade for upgrades in heart failure with reduced ejection fraction
Cecilia Linde
Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial
Frederick Raal 1*, Nyda Fourie2, Russell Scott 3, Dirk Blom 4, Matthys De Vries Basson5, Meral Kayikcioglu 6, Kate Caldwell7, David Kallend7 and Evan Stein 7, for the LIBerate-HeFH Investigators
Third generation PCSK9-inhibitors
Ulrich Laufs 1*, Matthias Blüher2, and Berend Isermann
A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers
Remco de Brouwer 1,2†, Wouter P. te Rijdt 1,2,3†‡ , Edgar T. Hoorntje 2,4 , Ahmad Amin5,6‡ , Folkert W. Asselbergs 5,6,7,8 , Moniek G.P.J. Cox1 , Jeroen F. van der Heijden7,9 , Hans Hillege 1 , Jacco C. Karper1 , Belend Mahmoud 1 , Peter van der Meer 1 , Anton Oomen10 , Anneline S.J.M. te Riele 7‡ , Herman H.W. Silljé 1 , Hanno L. Tan 2,5,6‡ , Jan Peter van Tintelen 2,11‡ , Dirk J. van Veldhuisen 1 , Berend Daan Westenbrink1 , Ans C.P. Wiesfeld1 , Tineke P. Willems 12 , Paul A. van der Zwaag 4 , Arthur A.M. Wilde 5,6‡ , Rudolf A. de Boer 1,13 , and Maarten P. van den Berg
Auditory stimulation of sleep slow waves enhances left ventricular function in humans
Stephanie Huwiler 1, Manuel Carro-Dom?nguez 1, Fabia M. Stich 1, Rossella Sala1, Florent Aziri1, Anna Trippel 1, Tabea Ryf2, Susanne Markendorf 2, David Niederseer 2, Philipp Bohm 2, Gloria Stoll1, Lily Laubscher1, Jeivicaa Thevan3, Christina M. Spengler 4,5, Joanna Gawinecka 3, Elena Osto 3, Reto Huber 6,7,8,9, Nicole Wenderoth 1,7,10, Christian Schmied 2†, and Caroline Lustenberger 1,6,7*
A thunder out of the blue
Nicolas Amabile 1*, Khalil Mahmoudi1, and Fréderic A. Sebag
Biventricular arrhythmogenic cardiomyopathy: 12-year natural history
Maria Cristina Procopio 1,2, Francisco Alpendurada1, and Chiara Bucciarelli-Ducci
